MURAL ONCOLOGY PLC
10 Earlsfort Terrace
Dublin 2, D02 T380, Ireland
November 15, 2024
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
| Re: | Mural Oncology plc |
Registration Statement on Form S-3
File No. 333-283198
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Mural Oncology plc (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-283198), so that it may become effective at 4:30 p.m. Eastern time on November 19, 2024, or as soon thereafter as practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff.
| Very truly yours, | ||
| MURAL ONCOLOGY PLC | ||
| By: | /s/ Maiken Keson-Brookes | |
| Name: Maiken Keson-Brookes | ||
| Title: Chief Legal Officer | ||
| cc: | Stuart M. Falber, Esq. |
Scott N. Lunin, Esq.
Wilmer Cutler Pickering Hale and Dorr LLP